Prime Medicine logo

Prime Medicine Share Price (NASDAQ: PRME)

$3.24

-0.2

(-5.81%)

Last updated on

Check the interactive Prime Medicine Stock chart to analyse performance

Prime Medicine stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.19
    Today's High:$3.47

    Day's Volatility :8.21%

  • 52 Weeks Low:$1.11
    52 Weeks High:$5.17

    52 Weeks Volatility :78.53%

Prime Medicine Stock Returns

PeriodPrime Medicine, Inc.Index (Russel 2000)
3 Months
172.27%
0.0%
6 Months
44.97%
0.0%
1 Year
-16.06%
0.0%
3 Years
-78.92%
-4.7%

Prime Medicine, Inc. Key Stats

Check Prime Medicine key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.44
Open
$3.45
Today's High
$3.47
Today's Low
$3.185
Market Capitalization
$613.3M
Today's Volume
$3.0M
52 Week High
$5.17
52 Week Low
$1.11
Revenue TTM
$5.0M
EBITDA
$-197.4M
Earnings Per Share (EPS)
$-1.56
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-154.81%

Stock Returns calculator for Prime Medicine Stock including INR - Dollar returns

The Prime Medicine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Prime Medicine investment value today

Current value as on today

₹89,222

Returns

₹10,778

(-10.78%)

Returns from Prime Medicine Stock

₹16,062 (-16.06%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Prime Medicine Stock

-61.9%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Prime Medicine Shares from India has dropped by -61.9% over the past 30 days, indicating reduced transactional activity.

-58%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Prime Medicine Stock from India on INDmoney has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Prime Medicine, Inc.

  • Name

    Holdings %

  • Alphabet Inc

    11.19%

  • T. Rowe Price Investment Management,Inc.

    4.82%

  • BlackRock Inc

    3.20%

  • FMR Inc

    2.78%

  • Vanguard Group Inc

    2.70%

  • Nikko Asset Management Americas Inc

    2.17%

Analyst Recommendation on Prime Medicine Stock

Rating
Trend

Buy

    76%Buy

    23%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Prime Medicine(by analysts ranked 0 to 5 stars)

Prime Medicine Share Price Target

What analysts predicted

Upside of 112.62%

Target:

$6.89

Current:

$3.24

Prime Medicine share price target is $6.89, a slight Upside of 112.62% compared to current price of $3.24 as per analysts' prediction.

Prime Medicine Stock Insights

  • Price Movement

    In the last 7 days, PRME stock has moved down by -8.7%
  • PRME vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 94.2%
  • Price to Sales

    ForPRME every $1 of sales, investors are willing to pay $83.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Prime Medicine Technicals Summary

Sell

Neutral

Buy

Prime Medicine is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Prime Medicine, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Prime Medicine, Inc. logo
-13.37%
44.97%
-16.06%
-78.92%
-78.92%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Prime Medicine, Inc.

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Organization
Prime Medicine
Employees
214
CEO
Dr. Allan Reine M.D.
Industry
Miscellaneous

Key Management of Prime Medicine, Inc.

NameTitle
Mr. Jeffrey D. Marrazzo M.B.A., M.P.A.
Executive Chair
Dr. Allan Reine M.D.
CEO & Director
Dr. Keith Michael Gottesdiener M.D., Ph.D.
Consultant
Dr. Andrew Anzalone M.D., Ph.D.
Co-Founder
Dr. David R. Liu Ph.D.
Co-Founder & Member of Scientific Advisory Board
Dr. Ann L. Lee Ph.D.
Chief Technical Officer
Mr. Ryan E. Brown J.D.
Chief Legal Officer
Ms. Niamh Alix
Chief Human Resources Officer
Mr. Mohammed Asmal M.D., Ph.D.
Senior VP & Head of Clinical

Important FAQs about investing in PRME Stock from India :

What is Prime Medicine share price today?

Prime Medicine share price today is $3.24 as on at the close of the market. Prime Medicine share today touched a day high of $3.47 and a low of $3.19.

What is the 52 week high and 52 week low for Prime Medicine share?

Prime Medicine share touched a 52 week high of $5.17 and a 52 week low of $1.11. Prime Medicine stock price today i.e. is closed at $3.24, lower by 37.33% versus the 52 week high.

How to invest in Prime Medicine Stock (PRME) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Prime Medicine on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Prime Medicine Shares that will get you 0.4630 shares as per Prime Medicine share price of $3.24 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Prime Medicine Stock (PRME) from India?

Indian investors can start investing in Prime Medicine (PRME) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Prime Medicine stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Prime Medicine share’s latest price of $3.24 as on August 30, 2025 at 1:29 am IST, you will get 3.0864 shares of Prime Medicine. Learn more about fractional shares .

What are the returns that Prime Medicine has given to Indian investors in the last 5 years?

Prime Medicine stock has given -78.92% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?